Ignite Creation Date:
2024-05-06 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 2:22 PM
Study NCT ID:
NCT05193448
Status:
COMPLETED
Last Update Posted:
2023-05-24
First Post:
2021-12-31
Brief Title:
A Non-interventional Ambispective Real-world Cohort of rEfractory and reLapsed RR FLT3 Mutated Acute MyEloid Leukemia AML Patients Treated With Gilteritinib in FrANCE
Sponsor:
Organization:
French Innovative Leukemia Organisation
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
6 Months
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
177
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 82060 |
Who Masked List: